- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 811
Kyn Therapeutics binds Celgene investment
UT Austin-founded Kyn Therapeutics has been backed by Celgene in a strategic pact that also includes a $80m non-equity payment, giving Celgene the right to license two programs.
Jan 18, 2019Lime lines up $400m round
The scooter and bicycle rental service, which counts Uber and Alphabet as backers, is reportedly set to raise funding at a $2bn valuation.
Jan 17, 2019CommonGrounds works up $100m series A
Seed investor Pacifica returned to back the workspace provider in a series A round that will fund its expansion to approximately 50 locations in the next two years.
Jan 17, 2019Waterloo puts Velocity behind angel fund
University of Waterloo hopes to raise $1.2m to $1.8m for an angel fund to make equity investments in the winners of its Velocity Fund Finals competition.
Jan 17, 2019UNLV touts Food Genes and Me
Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.
Jan 17, 2019Alation aligns with Salesforce to raise $50m
Salesforce Ventures has backed the data cataloguing software producer in a series C round that took its funding to $82m altogether.
Jan 17, 2019Bringg receives $25m series C delivery
Next47 has joined existing investors including Coca-Cola, Ituran and Salesforce in the round, which increased the logistics software provider's total funding to $53m.
Jan 17, 2019Trice Medical traverses series C extension
The orthopaedic diagnostics equipment developer has added $18.5m to a series C round featuring Smith & Nephew that now stands at $37.6m.
Jan 17, 2019Scout RFP procures $33m
Workday Ventures and Salesforce Ventures both contributed to the business procurement management platform's series C round, taking its total funding past $60m.
Jan 17, 2019Vast Therapeutics inhales $15m
The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .
Jan 17, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


